{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:33:42Z","timestamp":1787582022282,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014139","name":"CIBERONC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB16\/12\/00400"],"award-info":[{"award-number":["CB16\/12\/00400"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01166"],"award-info":[{"award-number":["PI19\/01166"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["EQC2019-005419-P"],"award-info":[{"award-number":["EQC2019-005419-P"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011824","name":"European Academy of Allergy and Clinical Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jaip.2023.02.007","type":"journal-article","created":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T02:27:59Z","timestamp":1676687279000},"page":"1536-1547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Bone and Cytokine Markers Associated With Bone Disease in Systemic Mastocytosis"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0134-617X","authenticated-orcid":false,"given":"Tiago Azenha","family":"Rama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Filipa","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Matito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jara-Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mayado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier I.","family":"Mu\u00f1oz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Cavaleiro-Rufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Garc\u00eda-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"\u00d3rf\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sanchez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"\u00c1lvarez-Twose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.02.007_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised","article-title":"Mastocytosis","author":"Horny","year":"2017"},{"key":"10.1016\/j.jaip.2023.02.007_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","article-title":"Bone involvement and osteoporosis in mastocytosis","volume":"34","author":"Rossini","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2023.02.007_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib4","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00198-016-3539-1","article-title":"Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis","volume":"27","author":"Rossini","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jaip.2023.02.007_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11154-016-9362-3","article-title":"Endocrine manifestations of systemic mastocytosis in bone","volume":"17","author":"Greene","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jaip.2023.02.007_bib6","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.iac.2018.04.013","article-title":"Bone disease in mastocytosis","volume":"38","author":"Orsolini","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2023.02.007_bib8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","article-title":"Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis","volume":"49","author":"Rossini","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jaip.2023.02.007_bib9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41598-017-01101-y","article-title":"Histamine and histamine H4 receptor promotes osteoclastogenesis in rheumatoid arthritis","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2023.02.007_bib10","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2353\/ajpath.2009.080871","article-title":"Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts","volume":"174","author":"Biosse-Duplan","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaip.2023.02.007_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1164\/ajrccm.154.3.8810600","article-title":"Inhaled tryptase causes bronchoconstriction in sheep via histamine release","volume":"154","author":"Molinari","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.02.007_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-065X.2007.00509.x","article-title":"Mast cell tryptases and chymases in inflammation and host defense","volume":"217","author":"Caughey","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2023.02.007_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2005.11.021","article-title":"Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice","volume":"530","author":"Ui","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaip.2023.02.007_bib14","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.ATV.18.11.1707","article-title":"Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques","volume":"18","author":"Johnson","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaip.2023.02.007_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","article-title":"Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond","volume":"5","author":"Walsh","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jaci.2012.12.674","article-title":"Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis","volume":"131","author":"Teodosio","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib17","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jaci.2013.06.019","article-title":"Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis","volume":"132","author":"Rabenhorst","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2023.02.007_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000091172","article-title":"Elevated tryptase levels are associated with greater bone density in a cohort of patients with mastocytosis","volume":"139","author":"Kushnir-Sukhov","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","article-title":"Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis","volume":"25","author":"Sperr","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaip.2023.02.007_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings","volume":"25","author":"Horny","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaip.2023.02.007_bib22","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.02.007_bib23","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jaip.2023.02.007_bib24","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2023.02.007_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00428-022-03423-3","article-title":"The international consensus classification of mastocytosis and related entities","volume":"482","author":"Leguit","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jaip.2023.02.007_bib26","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.02.007_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaci.2015.05.008","article-title":"Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis","volume":"137","author":"Alvarez-Twose","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","article-title":"Prostaglandins in bone: bad cop, good cop?","volume":"21","author":"Blackwell","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jaip.2023.02.007_bib29","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1080\/21691401.2018.1489264","article-title":"Cysteinyl leukotriene receptor 1 (cysLT1R) regulates osteoclast differentiation and bone resorption","volume":"46","author":"Zheng","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.jaip.2023.02.007_bib30","first-page":"2387","article-title":"Montelukast inhibits RANKL-induced osteoclast formation and bone loss via CysLTR1 and P2Y12","volume":"18","author":"Kang","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jaip.2023.02.007_bib31","series-title":"Anaphylaxis and Hypersensitivity Reactions","first-page":"47","article-title":"Mast cells: effector cells of anaphylaxis","author":"Tsai","year":"2011"},{"key":"10.1016\/j.jaip.2023.02.007_bib32","article-title":"The role of inflammatory cytokines, the RANKL\/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis","volume":"2013","author":"Weitzmann","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.jaip.2023.02.007_bib33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ng2076","article-title":"Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL","volume":"39","author":"Sobacchi","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.02.007_bib34","doi-asserted-by":"crossref","first-page":"75.e1","DOI":"10.1016\/j.amjmed.2012.07.018","article-title":"Bone complications of mastocytosis: a link between clinical and biological characteristics","volume":"126","author":"Guillaume","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2023.02.007_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11914-009-0023-2","article-title":"Proinflammatory cytokines and osteoporosis","volume":"7","author":"McLean","year":"2009","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jaip.2023.02.007_bib36","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3390\/ijms20092093","article-title":"The role of macrophage in the pathogenesis of osteoporosis","volume":"20","author":"Yang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2023.02.007_bib37","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fendo.2018.00788","article-title":"Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma","volume":"9","author":"Harmer","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jaip.2023.02.007_bib38","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4110\/in.2018.18.e8","article-title":"Regulation of osteoclast differentiation by cytokine networks","volume":"18","author":"Amarasekara","year":"2018","journal-title":"Immune Netw"},{"key":"10.1016\/j.jaip.2023.02.007_bib39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000063858","article-title":"Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients","volume":"128","author":"Theoharides","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12634","article-title":"Mast cells as sources of cytokines, chemokines, and growth factors","volume":"282","author":"Mukai","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2023.02.007_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/leu.2015.176","article-title":"Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression","volume":"30","author":"Mayado","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2023.02.007_bib42","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3389\/fimmu.2018.01508","article-title":"Interferon-gamma-mediated osteoimmunology","volume":"9","author":"Tang","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fimmu.2020.00163","article-title":"The role of mast cells in bone metabolism and bone disorders","volume":"11","author":"Ragipoglu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib44","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1210\/jc.2017-01127","article-title":"Diagnosis and management of osteopetrosis: Consensus Guidelines from the Osteopetrosis Working Group","volume":"102","author":"Wu","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaip.2023.02.007_bib45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/bonekey.2014.22","article-title":"Osteoimmunology: oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease","volume":"3","author":"Sims","year":"2014","journal-title":"Bonekey Rep"},{"key":"10.1016\/j.jaip.2023.02.007_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","article-title":"Bone turnover markers: use in osteoporosis","volume":"8","author":"Naylor","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaip.2023.02.007_bib47","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1038\/bcj.2016.109","article-title":"Measurement of beta-isomerized C-terminal telopeptide of type I collagen in patients with POEMS syndrome: diagnostic, prognostic, and follow-up utilities","volume":"6","author":"Huang","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jaip.2023.02.007_bib48","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/jbmr.3532","article-title":"Unique variant of NOD2 pediatric granulomatous arthritis with severe 1,25-dihydroxyvitamin D-mediated hypercalcemia and generalized osteosclerosis","volume":"33","author":"Whyte","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jaip.2023.02.007_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/pros.20311","article-title":"Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma","volume":"66","author":"Brasso","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.jaip.2023.02.007_bib50","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00223-015-9969-5","article-title":"Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis","volume":"96","author":"Rossini","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jaip.2023.02.007_bib51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0714.2010.00996.x","article-title":"Mastocytosis: oral implications of a rare disease","volume":"40","author":"Rama","year":"2011","journal-title":"J\u00a0Oral Pathol Med"},{"key":"10.1016\/j.jaip.2023.02.007_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00365513.2015.1087045","article-title":"Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women","volume":"76","author":"Wei","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jaip.2023.02.007_bib53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/biom11010122","article-title":"Focus on osteosclerotic progression in primary myelofibrosis","volume":"11","author":"Spampinato","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jaip.2023.02.007_bib54","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3390\/ijms22052458","article-title":"Genetic regulation of tryptase production and clinical impact: hereditary alpha tryptasemia, mastocytosis and beyond","volume":"22","author":"Sprinzl","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2023.02.007_bib55","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.jaip.2021.03.005","article-title":"The genetic basis and clinical impact of hereditary alpha-tryptasemia","volume":"9","author":"Luskin","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.02.007_bib56","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/imr.12626","article-title":"The controversial role of mast cells in fibrosis","volume":"282","author":"Bradding","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2023.02.007_bib57","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1097-4652(199911)181:2<312::AID-JCP13>3.0.CO;2-1","article-title":"Mast cell tryptase does not alter matrix metalloproteinase expression in human dermal fibroblasts: further evidence that proteolytically-active tryptase is a potent fibrogenic factor","volume":"181","author":"Zhang","year":"1999","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jaip.2023.02.007_bib58","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.4049\/jimmunol.158.5.2310","article-title":"Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis","volume":"158","author":"Gruber","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib59","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1182\/blood.V90.10.3914","article-title":"Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell \u03b1- or \u03b2-tryptases","volume":"90","author":"Mirza","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2023.02.007_bib60","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease","volume":"128","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib61","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00432-019-03119-3","article-title":"An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis","volume":"146","author":"Riffel","year":"2020","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jaip.2023.02.007_bib62","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0046-8177(85)80252-5","article-title":"Bone marrow findings in systemic mastocytosis","volume":"16","author":"Horny","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaip.2023.02.007_bib63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2141.1996.4631004.x","article-title":"Implication of CD44 in adhesion-mediated overproduction of TGF-beta and IL-1 in monocytes from patients with bone marrow fibrosis","volume":"93","author":"Rameshwar","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2023.02.007_bib64","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/ard.2009.124511","article-title":"Systemic mastocytosis and bone involvement in a cohort of 75 patients","volume":"69","author":"Barete","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2023.02.007_bib65","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2011.293","article-title":"An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis","volume":"26","author":"Teodosio","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2023.02.007_bib66","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.10.020","article-title":"Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes","volume":"125","author":"Teodosio","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.02.007_bib67","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"Leboff","year":"2022","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jaip.2023.02.007_bib68","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jaip.2022.03.007","article-title":"Personalized management strategies in mast cell disorders: ECNM-AIM user\u2019s guide for daily clinical practice","volume":"10","author":"Valent","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"updated-by":[{"DOI":"10.1016\/j.jaip.2023.12.014","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823001861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823001861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:36:07Z","timestamp":1761975367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823001861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2213219823001861"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.02.007","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone and Cytokine Markers Associated With Bone Disease in Systemic Mastocytosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}